snoooop40

snoooop40

Although this chart lays out several different possibilities / outcomes, my belief is the pennant holds & this price per coin goes much higher. I am still aware of the significant risks regarding sudden drops and shake-outs. As we have seen in the past, price drops can fast, severe and relatively long lasting and therefor only risk what you can afford to lose.

snoooop40

A Golden-Cross is a bullish event. The SPDR GOLD TRUST (GLD) looks to be setting up for one in the next several days. I have marked up the last 2 times this has occurred with this instrument, with some data to keep in mind. As I have noted on the daily chart, it is important to understand that a Golden-Cross requires some serious momentum to push the 50-day...

snoooop40

Inovio's daily candle chart has completed a "classic" Head & Shoulders pattern as of Oct 2018. So far the rising neckline ($4.87 today) has provided support but looks as though it may give way. There does appear to be ~some support~ in the $4.70 - $4.74 area. If share price continues to trade in the ($4.80 - $5.10) range, a DEATH-CROSS of the 50 & 200 SMA's...

snoooop40

Over the last 3 years, Bombardier Relative Strength (14) has hit a peak of at least 70 **AFTER** hitting a low of 31 or lower. This chart shows roughly the relationship between share price & RSI as well as the "behavior" of these technical tools through the last 7 times this scenario has occurred.

snoooop40

Chart is showing what I believe to be a "classic" symmetrical triangle breakout. Currently seeing resistance at 2016's high ($2.80). Relative strength (14) today is ~67 and volume has been steadily increasing over the couple weeks. 6 month price target is $4.42 which represents an approximate 65% gain from today's prices ($2.68). Additionally there has been...

snoooop40

Comparing a few of the technical patterns that occurred before and during the massive corrections of 2000 & 2008, the S&P is showing signs of another large correction looming. (Again after ~ 7-8 years of bull-run). These types of monster moves play out over a period of months / years and therefor it would be diligent to observe these and other indicators over...

snoooop40

Clearly small-cap drug development companies like Celsion are "news driven" when it comes to movement of the price per share. I am not aware of any specific fundamental catalysts in the near term (although there are many possibilities in terms of updates to their ongoing trials / partnerships / or other) The chart is showing some positive signs of an upturn in the...

snoooop40

As an update to my last chart on Inovio, (Which failed to reach the price targets within he time-frame suggested), I still am witness to extremely Bullish signals. Patience is certainly a key when investing in micro-cap bio-tech stocks. Inovio maintains a robust pipeline, recently initiated a phase 1 DNA immunotherapy trial for breast, lung and pancreatic...

snoooop40

I hold a small long position in HEB and am looking to make a trade here in the ~upper-mid~ $0.20's. ($0.27ish hopefully). This short-term trade is based on the recent technical indicators included in my chart. The upper trend-line looks to be a good short-term target and as of today it sits at $0.36. Because of the nature of mall-cap bio-pharma, this is...

snoooop40

Inovio announced (July 23 / 2014) HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial. The price per share closed today @ $12.63, that's 11% lower than the post-announcement high of $14.20 and 20% lower than the 52 week high of $15.80. As the market digests this HUGE news and we await "detailed study findings will...

snoooop40

Peregrine looks to be setting up for a nice trade. If the PPS does get to and sees support at ~$1.60 area, we could see a pretty quick move back to ~$1.91 area. Peregrine has seen a big increase in short interest in the last couple months.(8,852,918 reported Jan 15 / 2014 & 15,974,009 reported Apr 30 / 2014. As with ALL biopharmaceutical companies, Peregrine...

snoooop40

As Vringo continues to successfully force settlements out of accused infringers of their intellectual property, the share price has been beaten down. The chart appears to be forming a descending triangle pattern. Although this pattern is normally considered a bearish formation, I believe there are technical indicators pointing to a possible B/O beyond the current...

snoooop40

This is really just an update to the chart I posted on Jan 11th 2014. We have seen some wilds swings with this stock over the last week, including a 3-day volume total >272 million shares on Jan 23rd, 24th &27th. Volume has been drying up somewhat over the last week as the price per share has pulled back below a key support / resistance point of $7.75....

snoooop40

Over that last ~couple~ weeks the shares of Vringo have had some HUGE swings between $3.09 & $4.45. Including some trading over $6.xx in the extended hours market. This is clearly a news driven stock and the recent volatility is due to the combination of court rulings and the MASSIVE short interest involved with this equity. (S.I. is somewhere near 25% of the...

snoooop40

This chart represents my view of the near term increase in price per share of Ariad Pharmaceuticals. I am long shares (small position) and am planning on adding significantly in the immediate future. Ariad has been through a couple major events recently and are in the midst of recovering (part of) a large gap-down that initiated in October 2013. I believe short...

snoooop40

I am holding a long position in Inovio (average cost ~$1.80). I fully expect this company to move much higher in 2014. Since my last chart (posted Dec 20th) (only 10 days ago), Inovio has moved up approximately ~30%. I think Inovio has much more room to run, but has shown a couple technical details that I'm hoping will provide an opportunity to add shares before...

snoooop40

The last 2 trading days brought about a nice breakout with volume. I expect the trend to continue upward as we approach the markman hearing (Feb 26th 2014) with Facebook and Linkedin. I expect the price per share to over-take the high of 2013 ($3.41) before the end of February. There will be plenty of twist and turns along the way.

snoooop40

Daily chart looks like it has, but still needs some confirmation. A move above the blue area (with some volume) would be enough for me to start a position. Also a retest and bounce off $0.30 would be enough. Watching for now. Good Luck...